DrugSupplement
Serine clinical trials
- studies test it
- 10
- open now
- 3
- in phase 3
- 2
- first study started
- 2013
Keep track of what changes. Save the Serine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 6
- Phase 3
- 2
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 10
The Lowy Medical Research Institute Limited (2) · Massachusetts General Hospital (2) · Meyer Children's Hospital IRCCS (1) · University College, London (1) · Elijah W. Stommel (1) · Aleksandra Stark (1) · Fundació Sant Joan de Déu (1) · Phoenix Neurological Associates, LTD (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Serine is read from its arms, and is right about nine times in ten.
Testing it · 10
- TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental DisordersRecruitingPhase 3Meyer Children's Hospital IRCCSNCT07377032Written as L-serine
- Study of Serine Supplementation to Protect Vision in MacTelNot yet recruitingPhase 3The Lowy Medical Research Institute LimitedNCT07342439Written as L-serine
- Hereditary Sensory Neuropathy Serine TrialRecruitingPhase 2University College, LondonNCT06113055Written as L-serine
- Serine and Fenofibrate Study in Patients With MacTel Type 2CompletedPhase 2The Lowy Medical Research Institute LimitedNCT04907084Written as Serine
- Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)TerminatedPhase 2Elijah W. StommelNCT03580616Written as L-Serine
- Phase IIa L-serine Trial for eADTerminatedPhase 2Aleksandra StarkNCT03062449Written as L-Serine
- Tolerability and Efficacy of L-Serine in Patients With GRIN-related EncephalopathyStatus unknownNot applicableFundació Sant Joan de DéuNCT04646447Written as L-serine
- L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1CompletedPhase 1/2Massachusetts General HospitalNCT01733407Written as L-serine
- Short Term Dietary Serine Supplementation and Circulating Serine LevelsWithdrawnNot applicableMassachusetts General HospitalNCT02528994Written as L-serine
- Determining the Safety of L-serine in ALSStatus unknownPhase 1/2Phoenix Neurological Associates, LTDNCT01835782Written as L-Serine
Codes
What other systems call Serine · ClinicalTrials.gg INT008191
- MeSH (NLM) D012694SerineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 452VLY9402SERINEConfirmed FDA, NLM, Wikidata
- RxNorm 9671Confirmed FDA, Wikidata
- Wikidata Q106345473L-serine zwitterionConfirmed FDA, NLM, Wikidata
- Wikidata Q183290L-serineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29613SerineConfirmed FDA, Wikidata
- DrugBank DB00133One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012694 | Serine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 452VLY9402 | SERINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9671 | — | Confirmed FDA, Wikidata |
| Wikidata | Q106345473 | L-serine zwitterion | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q183290 | L-serine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29613 | Serine | Confirmed FDA, Wikidata |
| DrugBank | DB00133 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.